Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.61 is 57% below its 5-year average of 6.14, near the low end of its 5-year range (2.61–12.89).
As of the fiscal period ended Tuesday, June 30, 2026. 20.28% below its 12-month average of 3.28.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.61.
QUICK RATIO (ACID-TEST)
2.61
QUICK RATIO (ACID-TEST) AVG TTM
3.28
QUICK RATIO (ACID-TEST) AVG 3Y
4.24
QUICK RATIO (ACID-TEST) AVG 5Y
6.14
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-20.28%
CURRENT VS 3Y AVG
-38.37%
CURRENT VS 5Y AVG
-57.44%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 635 covered companies
CURRENT VS SECTOR MEDIAN
-12.58%
vs the sector median at left
Bolt Biotherapeutics, Inc.
Market Cap
$6.92M
Quick Ratio (Acid-Test)
2.61
TTM Avg
3.28
3Y Avg
4.24
5Y Avg
6.14
Market Cap
$7.13M
Quick Ratio (Acid-Test)
1.52
TTM Avg
3.93
3Y Avg
10.24
5Y Avg
10.80
Market Cap
$6.70M
Quick Ratio (Acid-Test)
16.20
TTM Avg
7.76
3Y Avg
4.60
5Y Avg
3.08
Market Cap
$6.67M
Quick Ratio (Acid-Test)
10.21
TTM Avg
3.61
3Y Avg
3.34
5Y Avg
4.20
Market Cap
$7.20M
Quick Ratio (Acid-Test)
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$7.20M
Quick Ratio (Acid-Test)
0.18
TTM Avg
0.90
3Y Avg
2.06
5Y Avg
1.76
Market Cap
$7.25M
Quick Ratio (Acid-Test)
0.31
TTM Avg
1.26
3Y Avg
1.91
5Y Avg
5.52
Market Cap
$7.32M
Quick Ratio (Acid-Test)
2.63
TTM Avg
4.46
3Y Avg
3.65
5Y Avg
4.69
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | $6.92M | 2.61 | 3.28 | 4.24 | 6.14 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.13M | 1.52 | 3.93 | 10.24 | 10.80 |
| Aclarion, Inc. (ACON)vs › | $6.70M | 16.20 | 7.76 | 4.60 | 3.08 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.67M | 10.21 | 3.61 | 3.34 | 4.20 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.20M | 45.95 | 58.73 | 40.89 | 40.89 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.20M | 0.18 | 0.90 | 2.06 | 1.76 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.25M | 0.31 | 1.26 | 1.91 | 5.52 |
| KALA BIO, Inc. (KALA)vs › | $7.27M | 6.88 | 3.46 | 4.15 | 4.53 |
| Longeveron Inc. (LGVN)vs › | $7.32M | 2.63 | 4.46 | 3.65 | 4.69 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.33M | 1.37 | 3.92 | 4.12 | 3.73 |
Quick Ratio
2.61
Excludes inventory
Current Ratio
2.61
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.61 |
| 2026-03-31 | 3.51 |
| 2025-12-31 | 3.59 |
| 2025-09-30 | 3.57 |
| 2025-06-30 | 3.11 |
| 2025-03-31 | 3.13 |
| 2024-12-31 | 3.20 |
| 2024-09-30 | 3.16 |
| 2024-06-30 | 4.28 |
| 2024-03-31 | 5.68 |
| 2023-12-31 | 5.17 |
| 2023-09-30 | 6.69 |
| 2023-06-30 | 7.42 |
| 2023-03-31 | 8.10 |
| 2022-12-31 | 7.47 |
| 2022-09-30 | 7.23 |
| 2022-06-30 | 9.73 |
| 2022-03-31 | 10.16 |
| 2021-12-31 | 8.87 |
| 2021-09-30 | 9.39 |
| 2021-06-30 | 12.89 |
| 2021-03-31 | 22.58 |
| 2020-12-31 | 2.25 |
| 2020-09-30 | 4.01 |
| 2020-06-30 | 6.87 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 4.15 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
